Assignee
Nykode Therapeutics ASA
NO·5 granted patents·13 pending applications·1 citations·filing 2019–2024
Top patents by PatentIndex Score
18 records- 0181US2023303718A1Modified AntibodyNykode Therapeutics ASA·Filed 2023·Application pending·0 cites
- 0278US2023048561A1Modified AntibodyNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 0375US12059459B2Therapeutic anticancer neoepitope vaccineNykode Therapeutics ASA·Filed 2021·Granted Aug 13, 2024·1 cites·22 claims
- 0473US12516116B2Homodimeric protein constructsNykode Therapeutics ASA·Filed 2022·Granted Jan 6, 2026·0 cites·18 claims
- 0564US2024350601A1Therapeutic Anticancer Neoepitope VaccineNykode Therapeutics ASA·Filed 2024·Application pending·0 cites
- 0661US11479605B2Homodimeric protein constructsNykode Therapeutics ASA·Filed 2020·Granted Oct 25, 2022·0 cites·19 claims
- 0758US2024325526A1Immune-stimulatory compositions and use thereofNykode Therapeutics ASA·Filed 2024·Application pending·0 cites
- 0857US2025049910A1Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2Nykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 0952US2025195632A1Tolerance-inducing constructs and composition and their use for the treatment of immune disordersNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1051US2025222085A1Co-expression of constructs and immunostimulatory compoundsNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1151US2024252625A1Co-expression of constructs and immunoinhibitory compoundsNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1250US12220459B2Immune-stimulatory compositions and use thereofNykode Therapeutics ASA·Filed 2020·Granted Feb 11, 2025·0 cites·22 claims
- 1349US2025288654A1Tolerance-inducing constructs and compositions and their use for the treatment of immune disordersNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1449US2025339509A1Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseasesNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1542US12462898B2Method for selecting neoepitopesNykode Therapeutics ASA·Filed 2019·Granted Nov 4, 2025·0 cites·20 claims
- 1642US2023165952A1Betacoronavirus prophylaxis and therapyNykode Therapeutics ASA·Filed 2021·Application pending·0 cites
- 1742US2023293650A1Individualized therapeutic anticancer vaccineNykode Therapeutics ASA·Filed 2021·Application pending·0 cites
- 1840US2024173391A1Therapeutic combination for treating cancerNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nykode Therapeutics ASA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →